Spread the word, children are still not “small adults”

Pulmonary Circulation

Volumn 3, Issue 1, 2013, Pages 3-4

  Fike, Candice D ^a   Aschner, Judy L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84934766264     PISSN: 20458932     EISSN: 20458940     Source Type: Journal    
DOI: 10.4103/2045-8932.109909     Document Type: Editorial

References (7)

1. Cerro MJ, Abman S, Diaz G, Freudenthal AH, Freudenthal F, Harikrishnan S. A consensus approach to the classification of pediatric pulmonary hypertensive vascular disease: Report from the pvri pediatric taskforce, Panama 2011. Pulm Circ 2011:286-98.
2. Lammers AE, Adatia I, Cerro MJ, Diaz G, Freudenthal AH, Freudenthal F. Functional classification of pulmonary hypertension in children: Report from the PVRI pediatric task force, Panama 2011. Pulm Circ 2011:280-5.
3. Roberts JD Jr, Fineman JR, Morin FC 3rd, Shaul PW, Rimar S, Schreiver MD. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide study Group. N Engl J Med 1997; 336:605-10.
4. Finer NN, Barrington KJ. Nitric oxide for respiratory failure in infants born at or near term. Cochrane Database Syst Rev 2006;4: CD000399.
5. Khemani E, McElhinney DB, Rhein L, Andrade O, Lacro RV, Thomas KC. Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: Clinical features and outcomes in the surfactant era. Pediatrics 2007;120:1260-9.
6. Archer SL, Weir EK, Wilkins MR. Basic science of pulmonary arterial hypertension for clinicians: New concepts and experimental therapies. Circulation 2010;121:2045-66.
7. Stenmark KR, Meyrick B, Gaie N, Mooi WJ, mcmurtry IF. Animal models of pulmonary arterial hypertension: The hope for etiological discovery and pharmacological cure. Am J Physiol Lung Cell Mol Physiol 2009;297:L1013-32.